- Home
- BNR vs BMGL Comparison
BNR vs BMGL Comparison
Compare BNR & BMGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- BMGL
- Stock Information
- Founded
- BNR 2014
- BMGL 2001
- Country
- BNR China
- BMGL Singapore
- Employees
- BNR 674
- BMGL N/A
- Industry
- BNR Medical Specialities
- BMGL
- Sector
- BNR Health Care
- BMGL
- Exchange
- BNR Nasdaq
- BMGL NYSE
- Market Cap
- BNR 38.3M
- BMGL 32.7M
- IPO Year
- BNR 2020
- BMGL 2025
- Fundamental
- Price
- BNR $4.22
- BMGL $2.25
- Analyst Decision
- BNR
- BMGL
- Analyst Count
- BNR 0
- BMGL 0
- Target Price
- BNR N/A
- BMGL N/A
- AVG Volume (30 Days)
- BNR 29.7K
- BMGL 5.3M
- Earning Date
- BNR 08-21-2025
- BMGL 01-01-0001
- Dividend Yield
- BNR N/A
- BMGL N/A
- EPS Growth
- BNR N/A
- BMGL N/A
- EPS
- BNR N/A
- BMGL 0.02
- Revenue
- BNR $72,112,038.00
- BMGL $7,342,469.00
- Revenue This Year
- BNR $136.32
- BMGL N/A
- Revenue Next Year
- BNR N/A
- BMGL N/A
- P/E Ratio
- BNR N/A
- BMGL $116.27
- Revenue Growth
- BNR 0.53
- BMGL 2.28
- 52 Week Low
- BNR $2.18
- BMGL $0.91
- 52 Week High
- BNR $7.90
- BMGL $9.40
- Technical
- Relative Strength Index (RSI)
- BNR 63.77
- BMGL N/A
- Support Level
- BNR $3.06
- BMGL N/A
- Resistance Level
- BNR $3.50
- BMGL N/A
- Average True Range (ATR)
- BNR 0.21
- BMGL 0.00
- MACD
- BNR 0.05
- BMGL 0.00
- Stochastic Oscillator
- BNR 95.65
- BMGL 0.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About BMGL BASEL MEDICAL GROUP LTD
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.